Morning. Today, we see march-in rights return to the headlines, ponder how Eli Lilly’s plan to hike list prices in Europe may ...

When U.S. regulators aren’t in the room while global standards are written, the future of patient safety, medical innovation, and cybersecurity are at risk.

Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...

A record-low number of Americans are drinking, according to a new Gallup poll that has been tracking this data since 1939.

With U.S. funding for science at risk, a longtime advocate sees ‘light at the end of the tunnel’ in Washington.

Last November, in the days following Donald Trump’s election, leaders at the National Institutes of Health began discussing ...

Keeping blood pressure below 120/80 lowers risk of dementia, as well as heart and kidney disease, new guidelines say.

For more on Prasad’s return, go here; for a “Matt’s Take” on Prasad, go here; for the latest on investors’ attitudes toward ...

Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients ...

Kornbluth learned lessons from the Duke cancer fraud case that “have powerfully shaped my approach to leadership ever since.” ...

If you’ll be at Epic’s User Group Meeting next week, 1) I hope you get some good frozen custard or cheese curds while you’re ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...